IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools
3D Organoids 2022 : Bioengineering Special Issue: Application of 3D Organoids Technology in Cancer Therapy
3D Organoids 2022 : Bioengineering Special Issue: Application of 3D Organoids Technology in Cancer Therapy

3D Organoids 2022 : Bioengineering Special Issue: Application of 3D Organoids Technology in Cancer Therapy

N/A
Submission Deadline: July 31, 2022




Call for Papers

Dear Colleagues,

Organoid technology has been established as a state-of-the-art cell culture tool that has emerged to efficiently reveal pathophysiologies and provide therapeutic options for human diseases. They recapitulate the in vivo morphology, heterogeneous cell types, genetic signatures, and functionality of original organs. Cancer organoids can be expanded long-term and genetically modified, which allows for extended applications in cancer research. The development of cancer patient-derived organoids potentially enables cancer modeling, translational medicine, and personalized therapeutics of various diseases.

Generation stage-changed organoids have the potential to reveal the differences in cell selection, specification, and cancer diversity. Heterogeneous aggregation of multiple distinct cell types is required to make functional organoids by developing co-culture systems incorporated with stroma, blood vessels, immune cells, etc. Innovative engineering approaches for organoids and tumor microenvironment production and organization are great tools for modeling cancer development. The establishment of patient-derived tumor organoid biobanks helps us to gain new insights into developing personalized medicine for patients. This Special Issue aims to gather recent advances in human cancer organoid biobanks, novel co-culture systems, and application cases of cancer organoids in pathological and therapeutic research in order to bring about new understanding and potential treatments of cancer.

Areas to be covered in this Special Issue may include, but are not limited to:

Establishment of cancer biobanks.
Development of novel co-culture system.
Use of engineered organoids for cancer modeling.
Application of organoids for mechanistic research of cancer development.
Use of organoids as cancer model systems for personalized therapy.
Use of organoids as high-throughput drug screening for cancer therapy.

We welcome original research, methods, and review articles.

Please contact Sophie Wang ([email protected]) if you have any questions.

Dr. Ming Jiang
Guest Editor


Credits and Sources

[1] 3D Organoids 2022 : Bioengineering Special Issue: Application of 3D Organoids Technology in Cancer Therapy


Check other Conferences, Workshops, Seminars, and Events


OTHER TUMOR EVENTS

NursingandHealthcare 2024: 5th International Conference on Nursing and Healthcare
Spain
Sep 2, 2024
Cancers (ISSN 2072-6694). 2022: MDPI - CANCERS - Special Issue: Innate Immunity in Cancer Therapy
N/A
Radiooncology 2019: 21st International Conference on Radiooncology and Combinatorial Cancer Therapies
Orlando Airport 5750 T.G. Lee Blvd Orlan
May 30, 2019
SHOW ALL

OTHER CANCER EVENTS

NursingandHealthcare 2024: 5th International Conference on Nursing and Healthcare
Spain
Sep 2, 2024
Oncology Event 2024: Global Webinar on Oncology
Virtual Event
Jan 15, 2024
ENCS 2024: Elets National Cancer Summit & Awards
Mumbai, Maharashtra
Apr 19, 2024
mRNA 2024: 2024 mRNA Technology Conference
Boston, MA
Apr 21, 2024
FGRT SCPC 2024: Frontiers in Genetics Research Topic - Single Cell RNA Expression in Pancreatic Cancer
N/A
SHOW ALL